Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00171483
Status:
COMPLETED
Last Update Posted:
2008-01-28
First Post:
2005-09-12
Brief Title:
Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease GERD Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors PPIs
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease GERD Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors PPIs
Status:
COMPLETED
Status Verified Date:
2008-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study to assess the effects of tegaserod added to PPI therapy in the resolution of heartburn and regurgitation in patients with incomplete relief from PPIs
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None